Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002050709-25-000011·Pasithea Therapeutics Corp.
Schedule 13G ownership disclosure
PASITHEA THERAPEUTICS CORP
Common Stock, par value $0.0001 per share · CUSIP: 70261F202
Event date: 2025-11-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Squadron Master Fund LP
Shares: 1,649,790.00 · Class: 7.3%
- Squadron Capital Management LLC
Shares: 2,252,930.00 · Class: 9.9%
- Matthew Sesterhenn
Shares: 2,252,930.00 · Class: 9.9%
- William Blank
Shares: 2,252,930.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050709-25-000011
- Form type
- SCHEDULE 13G
- Filer
- Pasithea Therapeutics Corp.
- CIK
- CIK 1841330
- Filed
- Dec 05, 2025
- Reporting period
- Nov 28, 2025
- Description
- Schedule 13G beneficial ownership